Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rallybio (RLYB) Interest & Investment Income (2023 - 2025)

Historic Interest & Investment Income for Rallybio (RLYB) over the last 3 years, with Q3 2025 value amounting to $462000.0.

  • Rallybio's Interest & Investment Income fell 5314.4% to $462000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year decrease of 4972.18%. This contributed to the annual value of $4.2 million for FY2024, which is 3141.37% down from last year.
  • Latest data reveals that Rallybio reported Interest & Investment Income of $462000.0 as of Q3 2025, which was down 5314.4% from $523000.0 recorded in Q2 2025.
  • In the past 5 years, Rallybio's Interest & Investment Income registered a high of $1.6 million during Q2 2023, and its lowest value of $462000.0 during Q3 2025.
  • In the last 3 years, Rallybio's Interest & Investment Income had a median value of $1.1 million in 2024 and averaged $1.1 million.
  • In the last 5 years, Rallybio's Interest & Investment Income crashed by 1746.44% in 2024 and then crashed by 5424.32% in 2025.
  • Quarter analysis of 3 years shows Rallybio's Interest & Investment Income stood at $1.4 million in 2023, then tumbled by 43.99% to $811000.0 in 2024, then plummeted by 43.03% to $462000.0 in 2025.
  • Its Interest & Investment Income stands at $462000.0 for Q3 2025, versus $523000.0 for Q2 2025 and $644000.0 for Q1 2025.